Clinical Trials Logo

Clinical Trial Summary

Safety of Nabilone in reducing marijuana craving


Clinical Trial Description

Randomized double blind trial into the safety and efficacy of Cesemat for the treatment of marijuana use ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01025700
Study type Interventional
Source University of British Columbia
Contact
Status Completed
Phase Phase 2/Phase 3
Start date June 2009
Completion date October 2010

See also
  Status Clinical Trial Phase
Completed NCT01081119 - Brief Voluntary Alcohol and Drug Intervention for Middle School Youth Phase 2
Completed NCT00506753 - Motivation and Skills for Delta-9-tetrahydrocannabinol/Ethanol (THC/ETOH+) Teens in Jail N/A
Completed NCT01863095 - An Exercise App to Reduce Young Adults' MJ Use N/A
Completed NCT03518567 - Behavioral Economic Analysis of Demand for Marijuana Phase 2
Recruiting NCT06120855 - Study on Regulated Cannabis Sales in Pharmacies N/A
Completed NCT00743145 - Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana Phase 2
Completed NCT00650585 - An Effectiveness Trial of Project ALERT N/A
Recruiting NCT03909477 - Longitudinal Study of Xenon-129 MRI Imaging Effects of Cannabis Smoking
Completed NCT01536899 - Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
Completed NCT01394185 - Effects of Dronabinol (Oral THC) on Cannabis Use Phase 1/Phase 2
Completed NCT00107562 - Adolescent Safer Sex Social Network Intervention N/A
Active, not recruiting NCT00547963 - Brief Counseling to Reduce Injuries Among Emergency Department Patients Who Report Alcohol and Substance Use Phase 2/Phase 3
Completed NCT00743366 - Effect of Quetiapine on Marijuana Withdrawal and Relapse Phase 2